Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Screening for breast cancer, how often?

IMPAKT

26 - 28 Jun 2009

Published: 12 Feb 2010

Views: 10909

Rating:

Save

Dr James Mackay - University College London, UK

Speaking at IMPAKT 2009 in Brussels, Dr James Mackay, Senior Lecturer at the Department of Biology at UCL and Consultant Clinical Genetic Oncologist at the London Oncology Clinic discusses his work evaluating the effectiveness of annual mammography and screening programs in Russia.

Categories:
Breast
Screening

Related Videos

Choosing Wisely for young women with breast cancer: Radiotherapy

Dr Tabassum Wadasadawala - Tata Memorial Hospital, Mumbai, India

Choosing Wisely for young women with breast cancer: Radiotherapy ( Dr Tabassum Wadasadawala - Tata Memorial Hospital, Mumbai, India )

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

Psychological issues in familial cancer

Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India

Psychological issues in familial cancer ( Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India )

SABCS 2023: Latest breast cancer diagnostics guidelines

Prof Nadia Harbeck and Prof Giuseppe Curigliano

SABCS 2023: Latest breast cancer diagnostics guidelines ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )

Genomic testing: Awareness and effective communication between healthcare...

Prof Richard Simcock and Antonella Cardone

Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )

Short-course radiation as effective as standard treatment for breast cancer...

Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy ( Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA )

Community-based breast cancer control programme in the Philipines

Kara Magsanoc-Alikpala - ICanServe Foundation, Manila, Philippines

Community-based breast cancer control programme in the Philipines ( Kara Magsanoc-Alikpala - ICanServe Foundation, Manila, Philippines )

Initiatives for cancer control in Indonesia

Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta...

Initiatives for cancer control in Indonesia ( Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta, Indonesia )

PHERGain trial ID's early breast cancer cases that benefit from dual HER2...

Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain

PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )

More from ecancer